Gilead Sciences Inc (GILD)
110.00 x 1 112.47 x 2
Post-market by (Cboe BZX)
111.79 +0.63 (+0.57%) 03/28/25 [NASDAQ]
110.00 x 1 112.47 x 2
Post-market 111.79 unch (unch) 18:40 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 7,569,000 | 7,545,000 | 6,954,000 | 6,686,000 | 7,114,000 |
| Cost of Goods | 1,581,000 | 1,574,000 | 1,544,000 | 1,552,000 | 2,090,000 |
| Gross Profit | 5,988,000 | 5,971,000 | 5,410,000 | 5,134,000 | 5,024,000 |
| Operating Expenses | 3,536,000 | 5,083,000 | 2,766,000 | 9,456,000 | 3,411,000 |
| Operating Income | 2,452,000 | 888,000 | 2,644,000 | -4,322,000 | 1,612,000 |
| Interest Expense | 248,000 | 238,000 | 237,000 | 254,000 | 252,000 |
| Other Income | -37,000 | 306,000 | -354,000 | 90,000 | 293,000 |
| Pre-tax Income | 2,167,000 | 956,000 | 2,053,000 | -4,486,000 | 1,653,000 |
| Income Tax | 385,000 | -297,000 | 438,000 | -315,000 | 236,000 |
| Net Income Continuous | 1,782,000 | 1,253,000 | 1,615,000 | -4,171,000 | 1,417,000 |
| Minority Interests | N/A | 0 | N/A | N/A | -12,000 |
| Net Income | $1,783,000 | $1,253,000 | $1,614,000 | $-4,170,000 | $1,429,000 |
| EPS Basic Total Ops | 1.43 | 1.00 | 1.29 | -3.34 | 1.14 |
| EPS Basic Continuous Ops | 1.43 | 1.00 | 1.30 | -3.34 | 1.14 |
| EPS Diluted Total Ops | 1.43 | 1.00 | 1.29 | -3.34 | 1.14 |
| EPS Diluted Continuous Ops | 1.44 | 1.00 | 1.29 | -3.34 | 1.13 |
| EPS Diluted Before Non-Recurring Items | 1.90 | 2.02 | 2.01 | -1.32 | 1.72 |
| EBITDA(a) | $3,145,000 | $1,578,000 | $3,338,000 | $-3,632,000 | $2,301,000 |